Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.
According to the World Health Organization, 360 million people worldwide, including 32 million children, suffer from hearing loss caused by congenital defects or other factors. These factors include infectious disease, use of certain medicines, or exposure to excessive noise. Yet, there are currently no FDA-approved drugs to prevent or treat hearing loss.
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs for their ability to protect cochlear cells from the chemotherapy agent cisplatin. Cisplatin is used to treat a variety of cancers but causes irreversible hearing loss in up to 70% of patients.
Zuo and colleagues identified multiple compounds that protected cochlear cells from cisplatin, several of which are already approved to treat other conditions. Three of the ten most effective compounds were inhibitors of an enzyme called CDK2. One of these CDK2 inhibitors, kenpaullone, was more effective than four other compounds that are currently in clinical trials for treating hearing loss.
Injecting kenpaullone into the middle ear protected both mice and rats from cisplatin-induced hearing loss. Moreover, kenpaullone also protected the hearing of mice to noise as loud as 100 dB. “Given that 100-dB noise is in the range of noise insults commonly experienced by people in our society, kenpaullone could have significant clinical application in treating noise-induced hearing loss,” says Zuo.
In the case of cisplatin-induced hearing loss, kenpaullone appears to protect hair cells by preventing CDK2 from stimulating the production of toxic reactive oxygen species from the cells’ mitochondria.
“The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients,” Zuo says. “Modifications of the treatment regimens, additional optimization of the delivery methods via the use of hydrogels, and structural modifications of the compounds via medicinal chemistry could ensure even better results with CDK2 inhibitors in treating hearing loss in humans.”
The Latest on: Hearing loss
[google_news title=”” keyword=”Hearing loss” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hearing loss
- Resonating Struggle of Children Amidst India's Hearing Loss Crisison March 3, 2024 at 8:26 am
Childhood memories often revolve around familiar sounds like school bells and lullabies, but in India, over 300 newborns grapple with hearing loss daily, highlighting the need for awareness and ...
- AI-Powered Hearing Aids: A Breakthrough for Hearing Losson March 3, 2024 at 8:01 am
About 430 million people worldwide suffer from hearing loss, as per estimates from the World Health Organization (WHO). “Now, the world is becoming more and more dependent on hearing aids. The ear ...
- World Hearing Day 2024: Why early identification and intervention for hearing loss is necessaryon March 3, 2024 at 7:14 am
World Hearing Day 2024 is on Marc 3 to raise awareness on why early identification and intervention for hearing loss is necessary ...
- AI-enabled advanced hearing aids may help people with hearing losson March 3, 2024 at 6:13 am
Artificial Intelligence-(AI) enabled hearing devices can revolutionise solutions for people living with hearing impairment, said experts here on World Hearing Day on Sunday.
- Surgeons helping treat hearing loss in Malawion March 3, 2024 at 1:48 am
ENT surgeon David Strachan first visited Malawi in 2013 while on holiday. He and colleague Chris Bem now work closely with two audiologists, Chiko Chabaluka and Mwanaish Phiri, based at the Queen ...
- GN launches The New Norm – a stigma-busting image bank that challenges misperceptions about hearing loss and hearing aidson March 3, 2024 at 12:00 am
A Media Snippet accompanying this announcement is available by clicking on this link. Globally, 4 out of 5 people who need hearing aids don't wear them, leaving an estimated 344 million people missing ...
- On World Hearing Day 2024, know what causes hearing loss in one earon March 2, 2024 at 6:30 pm
Hearing loss is often associated with old age, especially those with diabetes and high blood pressure. Hearing loss in babies is also possible due to maternal infections during pregnancy. There are ...
- World Hearing Day sheds light on hearing losson March 2, 2024 at 4:00 pm
World Hearing Day sheds light on hearing loss Posted: March 3, 2024 | Last updated: March 3, 2024 Natural hearing loss comes with aging. However, with the increased use of headphones for work and ...
- How to Spot Hearing Loss as You Ageon March 1, 2024 at 6:45 am
Age-related hearing loss, or presbycusis, is incredibly common, affecting about 13 percent of adults in their 50s and over half of Americans over 70. While you can’t prevent it, there are ways to ...
- Using hearing aids can be frustrating for older adults. Specialists say these 5 tips can helpon February 29, 2024 at 12:21 pm
Reed co-authored the most definitive study to date of hearing issues in older Americans, published in JAMA Open Network last year. Previous studies excluded people 80 and older. But data became ...
via Bing News